Department of Intensive Care, CHU-Charleroi, Université Libre de Bruxelles, 92 Boulevard Janson, 6000 Charleroi, Belgium ; Experimental Medicine Laboratory, CHU-Charleroi, ULB 222 Unit, 6110 Montigny-Le-Tilleul, Belgium.
Biomed Res Int. 2013;2013:124021. doi: 10.1155/2013/124021. Epub 2013 Oct 28.
Infection is often difficult to recognize in critically ill patients because of the marked coexisting inflammatory process. Lack of early recognition prevents timely resuscitation and effective antimicrobial therapy, resulting in increased morbidity and mortality. Measurement of a biomarker, such as C-reactive protein (CRP) concentration, in addition to history and physical signs, could facilitate diagnosis. Although frequently measured in clinical practice, few studies have reported on the pathophysiological role of this biomarker and its predictive value in critically ill patients. In this review, we discuss the pathophysiological role of CRP and its potential interpretation in the inflammatory processes observed in critically ill patients.
在重症患者中,由于存在明显的共存炎症过程,感染常常难以识别。由于未能早期识别,导致复苏不及时和抗菌治疗效果不佳,从而增加发病率和死亡率。除了病史和体格检查外,测量生物标志物(如 C 反应蛋白(CRP)浓度)可能有助于诊断。尽管在临床实践中经常测量,但很少有研究报告这种生物标志物的病理生理学作用及其在重症患者炎症过程中的预测价值。在这篇综述中,我们讨论了 CRP 的病理生理学作用及其在重症患者炎症过程中可能的解释。